Barbara Ryan | Eloxx’s Investor Relations Officer |
Robert Ward | Chairman and Chief Executive |
David Snow | our Chief Business Officer |
Matt Goddeeris | Senior Principal Scientist |
Greg Williams | Chief Operating Officer |
Greg Weaver | Chief Financial Officer |
Good afternoon, everyone, and welcome to Eloxx Pharmaceuticals Second Quarter 2018 Earnings Webcast and Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Ms. Barbara Ryan, Eloxx’s Investor Relations Officer. Please begin.